Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder

Urologic Oncology: Seminars and Original Investigations

Volumn 29, Issue 3, 2011, Pages 259-264

  Halachmi, Sarel ^a   Moskovitz, Boaz ^a   Maffezzini, Massimo ^b   Conti, Giario ^c   Verweij, Fabrizio ^d   Kedar, Daniel ^e   Sandri, Sandro D ^f   Nativ, Ofer ^a   Colombo, Renzo ^g  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b GALLIERA HOSPITAL   (Italy)

^c SANT ANNA HOSPITAL   (Italy)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e RABIN MEDICAL CENTER   (Israel)

^f Magenta Hospital   (Italy)

^g SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Noninvasive bladder cancer; Progression; Recurrence; Safety; T1 high grade; Thermochemotherapy

Indexed keywords

BCG VACCINE; DOXORUBICIN; MITOMYCIN C;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CYSTOSCOPY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; HYPERTHERMIC THERAPY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE METASTASIS; OUTCOME ASSESSMENT; PAIN; PATIENT SAFETY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THERMOCHEMOTHERAPY; TRANSITIONAL CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA OF THE BLADDER; TRANSURETHRAL RESECTION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT INDICATION; URETHRA STRICTURE; URGE INCONTINENCE; URINE CYTOLOGY;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 79955728238     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.02.012     Document Type: Article

References (23)

1. Cookson M.S., Herr H.W., Zhang Z.F., et al. The treated natural history of high risk superficial bladder cancer: 15-Year outcome. J Urol 1997, 158:62-67.
2. Babjuk M., Oosterlink W., Sykvester R., et al. Guideline on Ta-T1 non-muscle invasive bladder cancer, update 2008. European Association of Urology Guidelines 2008, 3-21.
3. Guideline for the management of non-muscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update 2. J Urol 2007, 178:2314-2330.
4. Cookson M.S., Chang S.S., Wells N., et al. Complications of radical cystectomy for nonmuscle invasive disease: Comparison with muscle invasive disease. J Urol 2003, 169:101-104.
5. Colombo R., Da Pozzo L.F., Salonia A., et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 2003, 21:4270-4276.
6. Gofrit O.N., Shapiro A., Pode D., et al. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology 2004, 63:466-471.
7. Moskovitz B., Meyer G., Kravtzov A., et al. Thermo-chemotherapy for intermediate or high-risk recurrent superficial bladder cancer patients. Ann Oncol 2005, 16:585-589.
8. O'Donnell M.A., Boehle A. Treatment options for BCG failures. World J Urol 2006, 24:481-487.
9. Jakse G., Loidl W., Seeber G., et al. Stage T1, grade 3 transitional cell carcinoma of the bladder: An unfavorable tumor?. J Urol 1987, 137:39-43.
10. Kulkarni G.S., Finelli A., Fleshner N.E., et al. Optimal management of high-risk T1G3 bladder cancer: A decision analysis. PLoS Med 2007, 4:e284.
11. Cheng W.C., Chan S.F.P., Chan L.W., et al. Fifteen years experience on intravesical therapy of T1G3 urinary bladder cancer: Conservative approach. Jpn J Clin Oncol 2003, 34:202-205.
12. Margel D., Tal R., Golan S., et al. Long-term follow-up of patients with stage T1 high-grade transitional cell carcinoma managed by bacille Calmette-Guerin immunotherapy. Urology 2007, 69:78-82.
13. Hurle R., Losa A., Manzetti A., et al. Intravesical bacille Calmette-Guerin in Stage T1 grade 3 bladder cancer therapy: A 7-year follow-up. Urology 1999, 54:258-263.
14. Lebret T., Gaudez F., Herve J.M., et al. Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: Recurrence, progression, and success. Eur Urol 1998, 34:67-72.
15. Pansadoro V., Emiliozzi P., de Paula F., et al. Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-Year experience. Urology 2002, 59:227-231.
16. Patard J., Moudouni S., Saint F., et al. Tumor progression and survival in patients with T1G3 bladder tumors: Multicentric retrospective study comparing 94 patients treated during 17 years. Urology 2001, 58:551-556.
17. Peyromaure M., Zerbib M. T1G3 transitional cell carcinoma of the bladder: Recurrence, progression, and survival. BJU Int 2004, 93:60-63.
18. Paroni R., Salonia A., Lev A., et al. Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Br J Clin Pharmacol 2001, 52:273-278.
19. van der Heijden A.G., Hulsbergen-Van de Kaa C.A., Witjes J.A. The influence of thermochemotherapy on bladder tumours: An immunohistochemical analysis. World J Urol 2007, 25:303-308.
20. Brake M., Loertzer H., Horsch R., et al. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. J Urol 2000, 163:1697-1701.
21. Gacci M., Bartoletti R., Cai T., et al. Intravesical gemcitabine in BCG-refractory T1G3 transitional cell carcinoma of the bladder: A pilot study. Urol Int 2006, 76:106-111.
22. Dalbagni G., Russo P., Bochner B., et al. Phase II trial of intravesical gemcitabine in bacille Calmette-Guerin-refractory transitional cell carcinoma of the bladder. J Clin Oncol 2006, 24:2729-2734.
23. van der Heijden A.G., Kiemeney L.A., Gofrit O.N., et al. Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder. Eur Urol 2004, 46:65-71.